Miami, FLNCT06798012Now EnrollingIRB Ready

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Clinical Trial in Miami, FL

Access cutting-edge chronic inflammatory demyelinating polyradiculoneuropathy treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by Takeda

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions...

Expert Care in Miami

Access chronic inflammatory demyelinating polyradiculoneuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic inflammatory demyelinating polyradiculoneuropathy treatment provided free

Apply for This Miami Location

Check if you qualify for this chronic inflammatory demyelinating polyradiculoneuropathy clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Chronic Inflammatory Demyelinating Polyradiculoneuropathy Study in Miami

CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the body. This leads to muscle weakness and loss of sensation in arms and legs among other symptoms. Participants with CIDP can be treated with a protein called immunoglobulin (or IG). TAK-411 is a special type of immune globu

Sponsor: Takeda

Who Can Participate

Inclusion Criteria

The participant is at least 18 years of age, inclusive, at the time of signing the Informed Consent Form (ICF).
The participant has a body weight of less than or equal to (\<=) 150 kilogram (kg).
The participant has a documented diagnosis of typical CIDP, as confirmed by a neurologist specializing/experienced in neuromuscular diseases and consistent with the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) 2021 criteria.
The participant has responded to IgG treatment in the past (documented partial or complete resolution of neurological symptoms and deficits).
The participant has had disease activation within 18 months before screening, as documented in medical records and in the opinion of the investigator, defined as one of the following: 1. Clinically meaningful deterioration of symptoms on interruption or dose reduction of IgG treatment. 2. Clinically meaningful deterioration of symptoms requiring IgG treatment dose increase wi

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT06798012) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treatment Options in Miami, FL

If you're searching for chronic inflammatory demyelinating polyradiculoneuropathy treatment options in Miami, FL, this clinical trial (NCT06798012) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyradiculoneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic inflammatory demyelinating polyradiculoneuropathy clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Miami, FL

See all multiple myeloma clinical trials recruiting in Miami — not just this study.

Browse Multiple Myeloma Trials in Miami

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL